TD Cowen analyst Oliver Chen raised the firm’s price target on Beauty Health (SKIN) to $2.50 from $2 and keeps a Hold rating on the shares. The firm believes the CEO’s reset is working on managing device sales (30%) churn and fostering consumables innovation (70%), along with deeper provider engagement in its 35k installed base.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SKIN:
- Beauty Health: Strategic Reset Amidst Challenges Justifies Hold Rating
- Beauty Health initiated with a Buy at Roth Capital
- Beauty Health launches Hydrafacial Advisory Councils, Ambassador Network
- Beauty Health Modifies Indenture for Convertible Notes
- Beauty Health Co. Earnings Call Highlights Strong Performance